Work

H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1

Year: 2014

Type: article

Source: Antiviral Research

DOI: 10.1016/j.antiviral.2014.07.003

Authors: Aloys Tijsma, Hendrik Jan Thibaut, Stéphane A.H. Spieser, Armando De Palma, Mohamed Koukni, Eric Rhoden, Steve Oberste, Gerhard Pürstinger, Antonia Volny-Luraghi, Javier Martin, Arnaud Marchand, Patrick Chaltin, Johan Neyts, Pieter Leyssen

Institutions: KU Leuven, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Universität Innsbruck, National Institute for Biological Standards and Control

Language: English

Topic: Viral Infections and Immunology Research

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: World Health Organization, European Commission

Award: G8873110251

OpenAlex ID: W2082908414

FWCI: 1.371

Cites: 30

Cited by: 15

Related to: 10